Skip to main content
Equibles
KIDS logo

KIDS · Orthopediatrics Corp · Metrics

Track KIDS — free

Use KIDS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KIDS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$24.50 -0.21 (-0.85%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$639.69M
Shares
26.11M
Volume · Oct 23 174.64K Avg daily vol (3M) 224.98K

KIDS metrics

92 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$24.50
Market cap
$639.69M

Price action

20 metrics
Price change (1W)
+11.6%
Price change (30D)
+8.6%
Price change (3M)
+29.8%
Price change (6M)
+51.3%
Price change (YTD)
+38.0%
Price change (1Y)
+43.6%
Trailing year
Price change (5Y)
-62.3%
52-week high
$26.50
52-week low
$14.64
Change from 52-week high
-7.5%
Change from 52-week low
+67.3%
Annualized volatility
42.1%
Annualized volatility (3M)
38.0%
Beta
0.7
RSI (14D)
64.6
Price vs SMA 50
+6.3%
Price vs SMA 200
+26.8%
Avg volume (3M)
224,977
Relative volume
0.8
Average dollar volume
$5.16M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
26.11M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.8×
reciprocal yield 36.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
2.5×
reciprocal yield 39.5%
P / book
1.9
reciprocal yield 53.7%
FCF yield
-0.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
86.4
reciprocal yield 1.2%
Earnings yield
-6.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.0×
reciprocal yield 33.1%
EV / revenue historical average (5Y)
5.7×
reciprocal yield 17.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-27
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
73.7%
Operating margin
-11.9%
Trailing 12 months
Net margin
-15.7%
Gross profit (TTM)
$186.14M
Operating profit (TTM)
−$30.00M
Net income (TTM)
−$39.73M
Trailing 12 months
Diluted EPS (TTM)
$-1.68
FCF margin
-0.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$10.65
Gross profit per diluted share (TTM)
$7.84
Operating profit per diluted share (TTM)
$-1.27
EBITDA per diluted share (TTM)
$-0.33
Net income per diluted share (TTM)
$-1.68
Operating cash flow per diluted share (TTM)
$0.31
Free cash flow per diluted share (TTM)
$-0.07
Capital expenditures per diluted share (TTM)
$0.39
R&D per diluted share (TTM)
$0.39
Stock compensation per diluted share (TTM)
$0.71
Book value per share
$13.81

Growth

11 metrics
Revenue growth YoY
+15.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$252.72M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.5%
Year over year · more shares
Revenue CAGR (3Y)
+24.6%
Revenue CAGR (5Y)
+27.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-11.6%
Return on assets
-7.8%
Debt / equity
0.3
Current ratio
4.8
EBITDA (TTM)
−$7.67M
Free cash flow (TTM)
−$1.83M
Quick ratio
2.2
Interest coverage
-3.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$56.11M
Latest balance sheet
Cash & equivalents
$17.00M
Total assets
$511.39M
Total debt
$101.99M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$7.41M
Capital expenditures (TTM)
$9.24M
R&D (TTM)
$9.15M
SG&A (TTM)
—
Stock compensation (TTM)
$16.84M
R&D / revenue
3.6%
Stock compensation / revenue
6.7%

Ownership (13F)

9 metrics
13F filers
119
13F filer change QoQ
-3
Institutional ownership
63.4%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
26.8%
Private-fund adviser ownership
21.2%
Active holders' share change QoQ
+4.0%
Holder tenure
15.4
Price vs estimated holder cost
-9.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
8.9%

Short interest

3 metrics
Short interest
3.6%
Latest settlement · 5.5 days to cover
Days to cover
5.5d
Short-squeeze score
83 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$15.58M
Insider-sentiment score
18 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1425450 CUSIP 68752L100 13F (30d) 18 filings 18 filers Visit website Investor relations